This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Tax treatment influences index fund performance in IRAs. This guide breaks down how Roth and traditional IRAs compare in real‑world scenarios.
28,321 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...
Driven Brands generated $1.9 billion in revenue, signaling a powerful multi-brand approach in the auto aftermarket. B...
A new collaboration between Uber and Amazon's Zoox signals more than tech sharing. This alliance could redefine the e...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
NVIDIA led the AI hardware rally, but the backbone of today’s AI deployments sits in memory and storage. This piece e...
JB Straubel’s initial pitch to Elon Musk missed the mark on aviation, but his pivot to electric cars launched Tesla t...
A new class of buffer ETFs promises protection for the first 15% of losses while chasing stock gains without stress? ...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Google is advancing a Minnesota data-center complex powered by wind, solar, and the world’s largest long-duration bat...
A wave of generative AI tools is upending Microsoft’s per-seat Office model. With Copilot seats climbing and pricing ...
A six-page FDA memo quietly opens the door for certain nicotine products to reach the market before complete regulato...